335 related articles for article (PubMed ID: 18848155)
21. Severe congenital neutropenia.
Welte K; Zeidler C; Dale DC
Semin Hematol; 2006 Jul; 43(3):189-95. PubMed ID: 16822461
[TBL] [Abstract][Full Text] [Related]
22. Optimal use of G-CSF administration after hematopoietic SCT.
Trivedi M; Martinez S; Corringham S; Medley K; Ball ED
Bone Marrow Transplant; 2009 Jun; 43(12):895-908. PubMed ID: 19363527
[TBL] [Abstract][Full Text] [Related]
23. Peripheral blood stem cell mobilisation by granulocyte-colony stimulating factor in patients with acute and old myocardial infarction for intracoronary cell infusion.
Chang SA; Kang HJ; Lee HY; Kim KH; Hur J; Han KS; Park YB; Kim HS
Heart; 2009 Aug; 95(16):1326-30. PubMed ID: 19460773
[TBL] [Abstract][Full Text] [Related]
24. Clinical applications of granulocyte colony-stimulating factor: an update and summary.
Hübel K; Engert A
Ann Hematol; 2003 Apr; 82(4):207-13. PubMed ID: 12707722
[TBL] [Abstract][Full Text] [Related]
25. The use of granulocyte-colony-stimulating factor in volunteer unrelated hemopoietic stem cell donors.
Pamphilon D; Nacheva E; Navarrete C; Madrigal A; Goldman J
Transfusion; 2008 Jul; 48(7):1495-501. PubMed ID: 18373639
[TBL] [Abstract][Full Text] [Related]
26. Long-term safety of granulocyte colony-stimulating factor in normal donors: is it all clear?
Martino M; Fedele R; Massara E; Recchia AG; Irrera G; Morabito F
Expert Opin Biol Ther; 2012 May; 12(5):609-21. PubMed ID: 22444029
[TBL] [Abstract][Full Text] [Related]
27. Granulocyte colony-stimulating factor-based stem cell mobilization in patients with sickle cell disease.
Rosenbaum C; Peace D; Rich E; Van Besien K
Biol Blood Marrow Transplant; 2008 Jun; 14(6):719-23. PubMed ID: 18489998
[TBL] [Abstract][Full Text] [Related]
28. Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer's disease.
Sanchez-Ramos J; Cimino C; Avila R; Rowe A; Chen R; Whelan G; Lin X; Cao C; Ashok R
J Alzheimers Dis; 2012; 31(4):843-55. PubMed ID: 22751169
[TBL] [Abstract][Full Text] [Related]
29. High CD8+ lymphocyte dose in the autograft predicts early absolute lymphocyte count recovery after peripheral hematopoietic stem cell transplantation.
Atta EH; de Azevedo AM; Maiolino A; Coelho CJ; Sarcinelli SM; de Alvarenga Máximo C; Marra VL
Am J Hematol; 2009 Jan; 84(1):21-8. PubMed ID: 19006229
[TBL] [Abstract][Full Text] [Related]
30. Etoposide 1.0 g/m2 or 1.5 g/m2 combined with granulocyte colony-stimulating factor for mobilization of peripheral blood stem cells in patients with malignancy: efficacy and toxicity.
Li B; Yang JL; Shi YK; He XH; Han XH; Zhou SY; Liu P; Yang S; Zhang CG
Cytotherapy; 2009; 11(3):362-71. PubMed ID: 19037766
[TBL] [Abstract][Full Text] [Related]
31. The effect of granulocyte colony stimulating factor on neutrophil functions in children with neutropenia after chemotherapy in the course of neoplasma.
Czygier M; Dakowicz Ł; Szmitkowski M
Adv Med Sci; 2007; 52():143-6. PubMed ID: 18217407
[TBL] [Abstract][Full Text] [Related]
32. The role of granulocyte colony-stimulating factor in hematopoietic stem cell transplantation.
Tabbara IA; Ghazal CD; Ghazal HH
Cancer Invest; 1997; 15(4):353-7. PubMed ID: 9246158
[TBL] [Abstract][Full Text] [Related]
33. [Focus on granulocyte colony-stimulating factor-induced pulmonary toxicity].
Noël-Savina E; Descourt R
Bull Cancer; 2012 Feb; 99(2):211-7. PubMed ID: 22265942
[TBL] [Abstract][Full Text] [Related]
34. The five "Ws" for bone pain due to the administration of granulocyte-colony stimulating factors (G-CSFs).
Lambertini M; Del Mastro L; Bellodi A; Pronzato P
Crit Rev Oncol Hematol; 2014 Jan; 89(1):112-28. PubMed ID: 24041627
[TBL] [Abstract][Full Text] [Related]
35. G-CSF and GM-CSF concentrations and receptor expression in peripheral blood leukemic cells from patients with chronic myelogenous leukemia.
Lee J; Kim Y; Lim J; Kim M; Han K
Ann Clin Lab Sci; 2008; 38(4):331-7. PubMed ID: 18988925
[TBL] [Abstract][Full Text] [Related]
36. MPGN type I induced by granulocyte colony stimulating factor.
Magen D; Mandel H; Berant M; Ben-Izhak O; Zelikovic I
Pediatr Nephrol; 2002 May; 17(5):370-2. PubMed ID: 12042897
[TBL] [Abstract][Full Text] [Related]
37. Acute lung injury during G-CSF-induced neutropenia recovery: effect of G-CSF on pro- and anti-inflammatory cytokines.
Wiedermann FJ
Bone Marrow Transplant; 2005 Oct; 36(8):731. PubMed ID: 16025149
[No Abstract] [Full Text] [Related]
38. Congenital neutropenias.
Zeidler C; Schwinzer B; Welte K
Rev Clin Exp Hematol; 2003 Mar; 7(1):72-83. PubMed ID: 14692235
[TBL] [Abstract][Full Text] [Related]
39. Synergistic effects of granulocyte-colony stimulating factor on bone marrow stromal cell transplantation for mice cerebral infarct.
Hokari M; Kuroda S; Chiba Y; Maruichi K; Iwasaki Y
Cytokine; 2009 May; 46(2):260-6. PubMed ID: 19286390
[TBL] [Abstract][Full Text] [Related]
40. Safety and efficacy of consecutive cycles of granulocyte-colony stimulating factor, and an intracoronary CD133+ cell infusion in patients with chronic refractory ischemic heart disease: the G-CSF in angina patients with IHD to stimulate neovascularization (GAIN I) trial.
Kovacic JC; Macdonald P; Feneley MP; Muller DW; Freund J; Dodds A; Milliken S; Tao H; Itescu S; Moore J; Ma D; Graham RM
Am Heart J; 2008 Nov; 156(5):954-63. PubMed ID: 19061712
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
